1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Hernando V, Alejos B, Monge S, Berenguer J, Anta L, Vinuesa D, Palacios R, Muga R, Moreno S, Jarrin I.

    All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010

    BMC INFECTIOUS DISEASES . 13: 382-382. Nº de citas: 19

    [doi:10.1186/1471-2334-13-382]

  • Serrano-Villar S, Quereda C, Moreno A, Pérez-Elías MJ, Casado JL, Royuela A, Dronda F, Navas E, Hermida JM, Moreno S.

    Neutropenia During Therapy With Peginterferon and Ribavirin in HIV-Infected Subjects With Chronic Hepatitis C and the Risk of Infections

    CLINICAL INFECTIOUS DISEASES . 57(3): 458-464. Nº de citas: 4

    [doi:10.1093/cid/cit221]

  • Wikman P, Safont P, Del Palacio M, Moreno A, Moreno S, Casado JL.

    The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients

    NEPHROLOGY DIALYSIS TRANSPLANTATION . 28(8): 2073-2081. Nº de citas: 20

    [doi:10.1093/ndt/gft210]

  • Pérez-Molina JA, Sojo-Dorado J, Norman F, Monge-Maillo B, Díaz-Menéndez M, Albajar-Viñas P, López-Vélez R.

    Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment

    ACTA TROPICA . 127(2): 101-104. Nº de citas: 30

    [doi:10.1016/j.actatropica.2013.04.003]

  • Holguín A, Norman F, Martín L, Mateos ML, Chacón J, López-Vélez R, Pérez-Molina JA.

    Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs.

    Clinical and Vaccine Immunology . 20(8): 1197-1202. Nº de citas: 19

    [doi:10.1128/CVI.00221-13]

  • Savini H, Gautret P, Gaudart J, Field V, Castelli F, López-Vélez R, Lim PL, Shaw M, von Sonnenburg F, Loutan L, Simon F.

    Travel associated Diseases, Indian Ocean Islands, 1997-2010

    EMERGING INFECTIOUS DISEASES . 19(8): 1297-1301. Nº de citas: 19

    [doi:10.3201/eid1908.121739]

  • Stellbrink HJ, Reynes J, Lazzarin A, Voronin E, Pulido F, Felizarta F, Almond S, St Clair M, Flack N, Min S, SPRING-1 Team.

    Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.

    AIDS . 27(11): 1771-1778. Nº de citas: 145

    [doi:10.1097/QAD.0b013e3283612419]

  • Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJ, Nguyen BY, Teppler H, BENCHMRK Study Teams.

    Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.

    LANCET INFECTIOUS DISEASES . 13(7): 587-596. Nº de citas: 114

    [doi:10.1016/S1473-3099(13)70093-8]

  • Casado JL.

    Liver Toxicity in HIV-Infected Patients Receiving Novel Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors Etravirine and Rilpivirine

    AIDS REVIEWS . 15(3): 139-145. Nº de citas: 17

  • Kaulich-Bartz J, Dam W, May MT, Lederberger B, Widmer U, Phillips AN, Grabar S, Mocroft A, Vilaro J, van Sighem A, Moreno S, Dabis F, Monforte AD, Teira R, Ingle SM, Sterne JA.

    Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies

    AIDS . 27(10): 1641-1655. Nº de citas: 9

    [doi:10.1097/QAD.0b013e3283601199]

  • Sainz T, Serrano-Villar S, Díaz L, González Tomé MI, Gurbindo MD, de José MI, Mellado MJ, Ramos JT, Zamora J, Moreno S, Muñoz-Fernández MA.

    The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults

    AIDS . 27(9): 1513-1516. Nº de citas: 140

    [doi:10.1097/QAD.0b013e32835faa72]

  • Gasch O, Camoez M, Domínguez MA, Padilla B, Pintado V, Almirante B, Lepe JA, Lagarde M, Ruiz de Gopegui E, Martínez JA, Montejo M, Torre-Cisneros J, Arnáiz A, Goenaga MA, Benito N, Rodríguez-Baño J, Pujol M.

    Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 68(6): 1423-1430. Nº de citas: 42

    [doi:10.1093/jac/dkt016]

  • Berenguer J, Alvarez-Pellicer J, Carrero A, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Tural C, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Barquilla E, Bellón JM, González-García J.

    Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

    JOURNAL OF HEPATOLOGY . 58(6): 1104-1112. Nº de citas: 23

    [doi:10.1016/j.jhep.2013.01.042]

  • Díez-Aguilar M, Ruiz-Garbajosa P, Fernández-Olmos A, Guisado P, Del Campo R, Quereda C, Cantón R, Meseguer MA.

    Non-diphtheriae Corynebacterium species: an emerging respiratory pathogen

    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 32(6): 769-772. Nº de citas: 65

    [doi:10.1007/s10096-012-1805-5]

  • Casado JL, Iglesias V, del Palacio M, Marín A, Perez-Elías MJ, Moreno A, Moreno S.

    Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy

    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV . 25(12): 1599-1603. Nº de citas: 5

    [doi:10.1080/09540121.2013.793275]

  • Lo B, Grady C, Working Group on Ethics of the International AIDS Society.

    Ethical considerations in HIV cure research: points to consider

    Current Opinion in HIV and AIDS . 8(3): 243-249. Nº de citas: 75

    [doi:10.1097/COH.0b013e32835ea1c5]

  • Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD.

    Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Study(a)

    JOURNAL OF INFECTIOUS DISEASES . 207(9): 1359-1369. Nº de citas: 257

    [doi:10.1093/infdis/jit043]

  • Rosinska M, Marzec-Bogustawska A, Janiec J, Smolen-Dzirba J, Wasik T, Gniewosz J, Zalewska M, Murphy G, McKinney E, Porter K, CASCADE Collaboration In Eurocoord.

    High Percentage of Recent HIV Infection Among HIV-Positive Individuals Newly Diagnosed at Voluntary Counseling and Testing Sites in Poland

    AIDS RESEARCH AND HUMAN RETROVIRUSES . 29(5): 805-813. Nº de citas: 20

    [doi:10.1089/aid.2012.0314]